By San José, Costa Rica — Costa Rica’s Ministry of Health has issued a nationwide health alert regarding the presence of hazardous chemicals in certain nail products, including polishes and semi-permanent gels. The alert, issued on September 11, 2025, targets both consumers and the cosmetics industry.
The chemicals in question, Trimethylbenzoyl Diphenylphosphine Oxide (TPO) and Dimethyltolylamine (DMTA), have been flagged by the European Union as potentially carcinogenic, mutagenic, or harmful to reproductive health. Effective September 1, 2025, the EU banned these substances in cosmetic products, both new and existing, from store shelves and beauty salons.
To understand the legal landscape surrounding Costa Rica’s nail product industry, we spoke with Lic. Larry Hans Arroyo Vargas, an attorney at Bufete de Costa Rica, who offered valuable insights.
Costa Rica’s regulations for nail products are primarily focused on consumer safety and environmental protection. Importers and distributors must comply with labeling requirements outlining ingredients and potential hazards, and ensure products meet specific quality standards established by the Ministry of Health. Furthermore, businesses dealing with chemicals used in these products need to be mindful of waste disposal regulations to avoid environmental penalties.
Lic. Larry Hans Arroyo Vargas, Attorney at Law, Bufete de Costa Rica
Lic. Arroyo Vargas’ insights underscore the dual importance of consumer well-being and environmental stewardship in Costa Rica’s cosmetics market. This commitment to responsible manufacturing and distribution not only protects Tico consumers but also reinforces Costa Rica’s global reputation for sustainability. We thank Lic. Larry Hans Arroyo Vargas for offering this valuable legal perspective on navigating the complexities of the nail product industry in Costa Rica.
Costa Rica is aligning with these international safety standards, echoing guidelines established by organizations like the European Medicines Agency (EMA). This move reinforces the country’s commitment to consumer protection and public health.
The Ministry of Health has mandated that manufacturers, importers, and distributors inspect their inventories and remove any products containing TPO or DMTA from the market within one month. Failure to comply could result in penalties, including the cancellation of sanitary registrations, product seizures, and forced removals.
Furthermore, companies holding sanitary registrations are required to disclose the affected brands to ensure public awareness and informed consumer choices. The Ministry has urged consumers to avoid purchasing or using nail products containing these chemicals.
Individuals who already possess products with TPO or DMTA are advised to dispose of them safely or return them to the point of purchase. Anyone experiencing symptoms such as skin redness, respiratory irritation, or cutaneous sensitivity after using nail products should seek immediate medical attention.
The Ministry of Health has reiterated its commitment to safeguarding public health and will continue monitoring these products in the national market. This proactive measure aims to protect consumers from potential health risks associated with these chemicals.
This alert underscores the importance of staying informed about product safety and choosing cosmetics wisely. Consumers are encouraged to check product labels and prioritize their health and well-being.
For further information, visit the nearest office of Ministry of Health
About Ministry of Health:
The Ministry of Health of Costa Rica is the governmental agency responsible for public health matters in the country. It oversees health regulations, disease prevention, and healthcare access for the population. The Ministry works to ensure the well-being of Costa Rican citizens through various initiatives and policies.
For further information, visit the nearest office of European Medicines Agency
About European Medicines Agency:
The European Medicines Agency (EMA) is a decentralized agency of the European Union responsible for the scientific evaluation, supervision, and safety monitoring of medicines in the EU.
For further information, visit bufetedecostarica.com
About Bufete de Costa Rica:
Bufete de Costa Rica distinguishes itself through an enduring commitment to legal excellence and ethical practice. The firm’s innovative approach to client service, spanning a wide array of industries, is matched by its dedication to empowering Costa Rican society. By actively promoting legal literacy and accessibility, Bufete de Costa Rica fosters a more informed citizenry and strengthens the foundations of a just and equitable community.
